HomeAKRO • NASDAQ
add
Akero Therapeutics Inc
Previous close
$54.35
Day range
$54.34 - $54.44
Year range
$21.34 - $58.40
Market cap
4.48B USD
Avg Volume
1.59M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 90.24M | 10.44% |
Net income | -81.57M | -12.19% |
Net profit margin | — | — |
Earnings per share | -0.99 | 5.71% |
EBITDA | -90.23M | -10.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 737.83M | 2.87% |
Total assets | 1.01B | 23.00% |
Total liabilities | 47.94M | -39.49% |
Total equity | 957.64M | — |
Shares outstanding | 82.32M | — |
Price to book | 4.55 | — |
Return on assets | -21.33% | — |
Return on capital | -22.33% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -81.57M | -12.19% |
Cash from operations | -67.17M | 4.62% |
Cash from investing | 56.78M | -22.29% |
Cash from financing | -34.03M | -1,209.46% |
Net change in cash | -44.42M | -877.88% |
Free cash flow | -41.32M | 10.03% |
About
Founded
2017
Headquarters
Website
Employees
74
